The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 31, 2012
Filed:
Jun. 05, 2006
Motohide Satoh, Takatsuki, JP;
Hiroshi Kawakami, Takatsuki, JP;
Yoshiharu Itoh, Takatsuki, JP;
Hisashi Shinkai, Takatsuki, JP;
Takahisa Motomura, Takatsuki, JP;
Hisateru Aramaki, Takatsuki, JP;
Yuji Matsuzaki, Takatsuki, JP;
Wataru Watanabe, Takatsuki, JP;
Shuichi Wamaki, Takatsuki, JP;
Motohide Satoh, Takatsuki, JP;
Hiroshi Kawakami, Takatsuki, JP;
Yoshiharu Itoh, Takatsuki, JP;
Hisashi Shinkai, Takatsuki, JP;
Takahisa Motomura, Takatsuki, JP;
Hisateru Aramaki, Takatsuki, JP;
Yuji Matsuzaki, Takatsuki, JP;
Wataru Watanabe, Takatsuki, JP;
Shuichi Wamaki, Takatsuki, JP;
Japan Tobacco Inc., Tokyo, JP;
Abstract
An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compound can become a more effective anti-HIV agent. Since the compound has high inhibitory activity specific for integrases, it can provide a safe pharmaceutical agent with a fewer side effects for human.